Wholesale hUCT-MSC

Umbilical cord tissue-derived mesenchymal stromal cells for licensed MD, DO, NP and PA practices. 25 million or 10 million cells per vial, 97% post-thaw viability, and a dual-lab Certificate of Analysis on every lot.

  • FDA-Registered Facility
  • cGTP-Compliant (21 CFR Part 1271)
  • Dual-Lab COA Verified
  • NTA-Verified
  • USA Manufactured
Apply for wholesale accessTalk to our team

Individualized biologic · Not FDA-approved · Consult PCP

The 25M and 10M vials

Two vial sizes produced to the same lot standard and documented end to end. Specifications below; pricing and ordering on the product pages.

Individualized · Clinician-directed
25M hUCT-MSC vial
Individualized biologic

25M hUCT-MSC Vial

Cells
25 million per vial
Viability
97% post-thaw, independently verified
Tissue source
Umbilical cord tissue (Wharton's jelly)
Culture
3D hollow-fiber bioreactor, xeno-free and serum-free
Expansion
Population doublings tracked per lot
Release testing
Sterility, endotoxin, mycoplasma, viability, cell characterization
Storage
Liquid nitrogen preferred; −80 °C cryo freezer acceptable
Shipping
Frozen on dry ice, temperature monitored
IndividualizedNot FDA-approvedClinician-directedConsult PCP

Wharton's jelly tissue source from AATB-accredited establishment with this tissue category within scope of accreditation.

View product & pricing →
10M hUCT-MSC vial
Individualized biologic

10M hUCT-MSC Vial

Cells
10 million per vial
Viability
97% post-thaw, independently verified
Tissue source
Umbilical cord tissue (Wharton's jelly)
Culture
3D hollow-fiber bioreactor, xeno-free and serum-free
Expansion
Population doublings tracked per lot
Release testing
Sterility, endotoxin, mycoplasma, viability, cell characterization
Storage
Liquid nitrogen preferred; −80 °C cryo freezer acceptable
Shipping
Frozen on dry ice, temperature monitored
IndividualizedNot FDA-approvedClinician-directedConsult PCP
View product & pricing →

Why umbilical cord tissue

Cord tissue is donated after a healthy birth, from tissue that would otherwise be discarded, with no procedure on the donor. The cells come from Wharton's jelly, the connective tissue around the cord's vessels.

  • Neonatal source: the cells start their in-vitro life without an adult donor's age behind them.
  • Donor eligibility is determined from the birth mother under 21 CFR Part 1271, Subpart C.
  • Published comparisons report cord-derived MSCs expand faster and further in culture than adult bone marrow MSCs.
Read the full sourcing comparison →
Cross-section of a human umbilical cord labeled with two arteries, one vein, Wharton's jelly and the amniotic epithelium, with a zoomed view of stromal cells.
Wharton's jelly surrounds the cord's two arteries and one vein. Illustration.

From donation to your practice

Every step runs in an FDA-registered tissue establishment under cGTP (21 CFR Part 1271).

  1. Donation

    Consented donation after birth, with donor screening and testing under 21 CFR 1271.

  2. Isolation

    Cells are isolated from Wharton's jelly in the lab.

  3. 3D expansion

    Hollow-fiber bioreactor culture in xeno-free, serum-free conditions, with doublings tracked.

  4. Dual-lab release

    Two independent labs test sterility, endotoxin, mycoplasma, viability and identity.

  5. Cold chain

    Cryopreserved and shipped frozen on dry ice with temperature monitoring.

Cell age, on the record

Cultured cells have an age of their own: how many times they have divided in the lab. We track population doublings for each lot, so expansion history is part of the paperwork, not a guess.

How population doublings are measured →
Five culture flasks labeled P1 to P5 with doublings added at each passage and a running total of cumulative population doublings.
Cumulative population doublings across passages. Illustrative numbers, not Stem Nova lot data.

Included with every order

Lot documentation is available to review before you order.

Dual-lab COA
Lot-specific Certificates of Analysis from two independent laboratories: sterility, endotoxin, mycoplasma and cell characterization.
Viability report
Independent post-thaw viability by trypan blue exclusion, with passage number documented.
Donor eligibility summary
Screening summary under 21 CFR Part 1271, traceable from donation to vial.
Cold-chain records
Temperature monitoring for frozen shipment on dry ice.
Storage & handling guide
Storage and handling documentation to protect product integrity on arrival.
Account manager
One contact for ordering, documentation requests and product questions.
How to read our COAs →

Regulatory status, plainly

What these products are, and what they are not.

  • StatusIndividualized biologic. Not FDA-approved.
  • UseClinician-directed. Patients should consult their primary care provider.
  • ManufacturingFDA-registered tissue establishment, cGTP-compliant (21 CFR Part 1271), USA manufactured.
  • GuidanceStem Nova Network does not provide dosing or procedural guidance.
  • BuyersLicensed MD, DO, NP and PA practices only, verified before ordering.

Stem cell questions

More in the full FAQ.

What does Stem Nova Network supply?

Human umbilical cord tissue-derived mesenchymal stromal cells (hUCT-MSC) isolated from Wharton's jelly, supplied in 25-million-cell and 10-million-cell vials. They are individualized biologics and are not FDA-approved.

How is post-thaw viability verified?

By independent third-party laboratory testing using trypan blue exclusion. The result, 97% post-thaw viability, is documented on the lot's Certificate of Analysis.

How are the cells stored and shipped?

Vials ship frozen on dry ice with temperature monitoring. On arrival, liquid nitrogen storage is the preferred method; a −80 °C cryo freezer is also acceptable. Each shipment includes storage and handling documentation.

What is the regulatory status?

hUCT-MSC products are individualized and not FDA-approved. They are manufactured in an FDA-registered tissue establishment under cGTP (21 CFR Part 1271). Use is clinician-directed, and patients should consult their primary care provider.

Do you provide dosing or protocol guidance?

No. Stem Nova Network does not provide dosing or procedural guidance. The Biologics Integration Academy covers compliance, documentation and practice operations.

Who is eligible to purchase?

Licensed medical professionals (MD, DO, NP, PA) and their practice entities. Every applicant is verified before approval, typically within 24 hours. We do not sell to consumers.

Before you source hUCT-MSC

Cited explainers and sourcing guides for licensed practitioners.

Also available: topical exosome biologics

Five topical cosmetic exosome and secretome products from 3D bioreactor culture, with NTA-verified particle counts and dual-lab COAs.

Explore exosome biologics

Source with the paperwork in hand

Apply for a wholesale account to review lot-specific COAs and order. Licensed professionals only; applications are typically approved within 24 hours.

Apply for wholesale accessTalk to our team

For licensed medical professionals only. Exosome products are topical cosmetic products. hUCT-MSC products are individualized and not FDA-approved; use is clinician-directed, and patients should consult their primary care provider. Stem Nova Network does not provide dosing or procedural guidance. Products are not intended to diagnose, treat, cure, or prevent any disease. Stem Nova Network is a DBA of D1D Enterprises, Inc.